Balang, Samera .

HRN: 24-53-30  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/15/2026
LEVOFLOXACIN 5MG/ML, 100ML (VIAL)
05/15/2026
05/22/2026
IV
750
Q24
Dm Foot
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines